Dr. Armstrong is chair of the Department of Pediatric Oncology at the Dana-Farber Cancer Institute, and the David G. Nathan professor of pediatrics at the Dana-Farber Cancer Institute, Boston Children’s Hospital, and Harvard Medical School. He is also president of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. Dr. Armstrong’s research group has made seminal discoveries into leukemia biology and chromatin based epigenetic mechanisms in cancer. This work has spurred the development of several new classes of therapeutic agents that target epigenetic mechanisms and gene activity in cancer with many already being tested in clinical trials for both children and adults. Dr. Armstrong has served on multiple committees for AACR and he was the chair of the 2016 AACR Annual Meeting. His work has been recognized with awards such as the Paul Marks Prize for Cancer Research from Memorial Sloan Kettering Cancer Center, the E. Mead Johnson Award from the Society for Pediatric Research, and the Dameshek Prize from the American Society of Hematology. He is a member of the National Academy of Medicine.